Radiolabeled NanoLiposomes: A Novel Targeted Treatment for Rare and Central Nervous System Cancers

Time: 4:30 pm
day: Day One

Details:

  • Targeted radiotherapeutics for cancer
  • Lead investigational drug: Rhenium-186 NanoLiposome
  • U.S. ReSPECT clinical trials update

Speakers: